Understanding how the HIV-1 virus enters cells by studying its surface protein dynamics
Combining Molecular Simulations and Biophysical Methods to Characterize Conformational Dynamics of the HIV-1 Envelope Glycoprotein
This study is looking at a key part of the HIV virus that helps it infect people, with the goal of finding new ways to create vaccines and treatments that can better fight the virus and help patients stay healthy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Drexel University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10885177 on NIH RePORTER |
What this research studies
This research investigates the HIV-1 envelope glycoprotein, which is crucial for the virus's ability to infect human cells. By using advanced molecular simulations and biophysical methods, the study aims to characterize the conformational changes of this protein, which can inform the development of vaccines and antiviral therapies. Patients may benefit from insights gained about how the virus evades the immune system and how it can be targeted by new treatments. The research combines techniques like single-molecule FRET and mass spectrometry to explore the protein's dynamics at an atomic level.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals living with HIV-1 or those at high risk of infection.
Not a fit: Patients with other types of viral infections or those who are not infected with HIV-1 may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective vaccines and antiviral therapies for HIV-1.
How similar studies have performed: Previous research has shown success in understanding viral entry mechanisms using similar molecular dynamics approaches, indicating a promising avenue for this study.
Where this research is happening
Philadelphia, United States
- Drexel University — Philadelphia, United States (Active)
Researchers
- Principal investigator: Abrams, Cameron F — Drexel University
- Study coordinator: Abrams, Cameron F
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.